Can population differences in chemotherapy outcomes be inferred from differences in pharmacogenetic frequencies
10.1038/tpj.2012.26
Saved in:
Main Authors: | Loh, M., Chua, D., Yao, Y., Soo, R.A., Garrett, K., Zeps, N., Platell, C., Minamoto, T., Kawakami, K., Iacopetta, B., Soong, R. |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Article |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/110726 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Systemic therapies for pancreatic cancer - the role of pharmacogenetics
by: Soo, R.A., et al.
Published: (2014) -
THE EFFECTIVENESS OF INTERNET-BASED SUPPORTIVE CARE TO IMPROVE HEALTH OUTCOMES OF INDIVIDUALS WITH COLORECTAL CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS
by: SOONG WEN YI
Published: (2019) -
Differences between Asians & Caucasians in chemotherapeutic related outcomes in patients with colorectal cancer
by: CHUA HSIANG LIM, DARREN
Published: (2010) -
Clinical pharmacology and pharmacogenetics of gemcitabine
by: Wong, A., et al.
Published: (2014) -
Pharmacogenetics of Warfarin Should we test?
by: Pantep Angchaisuksiri, et al.
Published: (2022)